Published in Am J Trop Med Hyg on January 01, 2010
Epidemiology of dengue: past, present and future prospects. Clin Epidemiol (2013) 3.99
Economic impact of dengue illness in the Americas. Am J Trop Med Hyg (2011) 3.52
Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet (2012) 2.13
The history of dengue outbreaks in the Americas. Am J Trop Med Hyg (2012) 1.87
Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. PLoS Negl Trop Dis (2013) 1.81
From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil. PLoS Negl Trop Dis (2011) 1.70
Phylogeography and population dynamics of dengue viruses in the Americas. Mol Biol Evol (2012) 1.56
Lessons from malaria control to help meet the rising challenge of dengue. Lancet Infect Dis (2012) 1.54
Insecticide resistance in the dengue vector Aedes aegypti from Martinique: distribution, mechanisms and relations with environmental factors. PLoS One (2012) 1.52
Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach. PLoS Negl Trop Dis (2016) 1.44
Health Seeking Behaviour and Treatment Intentions of Dengue and Fever: A Household Survey of Children and Adults in Venezuela. PLoS Negl Trop Dis (2015) 1.44
Effects of local and regional climatic fluctuations on dengue outbreaks in southern Taiwan. PLoS One (2017) 1.41
Ecological, biological and social dimensions of dengue vector breeding in five urban settings of Latin America: a multi-country study. BMC Infect Dis (2014) 1.31
RNA-seq analyses of blood-induced changes in gene expression in the mosquito vector species, Aedes aegypti. BMC Genomics (2011) 1.24
A three-component biomarker panel for prediction of dengue hemorrhagic fever. Am J Trop Med Hyg (2012) 1.23
Dengue deaths in Puerto Rico: lessons learned from the 2007 epidemic. PLoS Negl Trop Dis (2012) 1.23
Utility of the tourniquet test and the white blood cell count to differentiate dengue among acute febrile illnesses in the emergency room. PLoS Negl Trop Dis (2011) 1.21
Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever. Clin Transl Sci (2012) 1.17
Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis. PLoS Negl Trop Dis (2016) 1.16
Dengue in the United States of America: a worsening scenario? Biomed Res Int (2013) 1.15
Worldwide spread of Dengue virus type 1. PLoS One (2013) 1.15
Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. PLoS Negl Trop Dis (2014) 1.13
Correlation of serotype-specific dengue virus infection with clinical manifestations. PLoS Negl Trop Dis (2012) 1.13
Viral and epidemiological determinants of the invasion dynamics of novel dengue genotypes. PLoS Negl Trop Dis (2010) 1.12
Factors associated with dengue mortality in Latin America and the Caribbean, 1995-2009: an ecological study. Am J Trop Med Hyg (2012) 1.09
Towards a Casa Segura: a consumer product study of the effect of insecticide-treated curtains on Aedes aegypti and dengue virus infections in the home. Am J Trop Med Hyg (2013) 1.09
Costs of dengue to the health system and individuals in Colombia from 2010 to 2012. Am J Trop Med Hyg (2015) 1.07
The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis. BMC Infect Dis (2014) 1.07
The 2012 Madeira dengue outbreak: epidemiological determinants and future epidemic potential. PLoS Negl Trop Dis (2014) 1.07
Spatiotemporal clustering, climate periodicity, and social-ecological risk factors for dengue during an outbreak in Machala, Ecuador, in 2010. BMC Infect Dis (2014) 1.05
Dengue: a new challenge for neurology. Neurol Int (2012) 1.04
Dengue: an escalating public health problem in Latin America. Paediatr Int Child Health (2012) 1.04
Spatial mapping of gene expression in the salivary glands of the dengue vector mosquito, Aedes aegypti. Parasit Vectors (2011) 1.03
Cost-effectiveness of novel system of mosquito surveillance and control, Brazil. Emerg Infect Dis (2013) 1.02
Clinical and laboratory features that discriminate dengue from other febrile illnesses: a diagnostic accuracy study in Rio de Janeiro, Brazil. BMC Infect Dis (2013) 1.01
Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol (2013) 0.99
Recent epidemiological trends of dengue in the French territories of the Americas (2000-2012): a systematic literature review. PLoS Negl Trop Dis (2014) 0.99
Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil. Am J Trop Med Hyg (2013) 0.98
Urban epidemic of dengue virus serotype 3 infection, Senegal, 2009. Emerg Infect Dis (2014) 0.97
Lung in dengue: computed tomography findings. PLoS One (2014) 0.96
Mosquitoes infected with dengue viruses in Brazil. Virol J (2010) 0.95
Why are people with dengue dying? A scoping review of determinants for dengue mortality. BMC Infect Dis (2015) 0.95
Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions. PLoS Negl Trop Dis (2013) 0.95
The dengue virus mosquito vector Aedes aegypti at high elevation in Mexico. Am J Trop Med Hyg (2012) 0.93
Economic Impact of Dengue: Multicenter Study across Four Brazilian Regions. PLoS Negl Trop Dis (2015) 0.92
International Health Regulations, Ebola, and Emerging Infectious Diseases in Latin America and the Caribbean. Am J Public Health (2015) 0.92
America's most distressed areas and their neglected infections: the United States Gulf Coast and the District of Columbia. PLoS Negl Trop Dis (2011) 0.91
Case series of fatal Leptospira spp./dengue virus co-infections-Puerto Rico, 2010-2012. Am J Trop Med Hyg (2014) 0.89
Detection of dengue virus NS1 antigen in infected Aedes aegypti using a commercially available kit. Am J Trop Med Hyg (2012) 0.88
Epidemiological Characteristics of Dengue Disease in Latin America and in the Caribbean: A Systematic Review of the Literature. J Trop Med (2017) 0.88
Lineage II of Southeast Asian/American DENV-2 is associated with a severe dengue outbreak in the Peruvian Amazon. Am J Trop Med Hyg (2014) 0.88
A social-ecological analysis of community perceptions of dengue fever and Aedes aegypti in Machala, Ecuador. BMC Public Health (2014) 0.87
Geographic expansion of the invasive mosquito Aedes albopictus across Panama--implications for control of dengue and Chikungunya viruses. PLoS Negl Trop Dis (2015) 0.87
Modeling dengue vector dynamics under imperfect detection: three years of site-occupancy by Aedes aegypti and Aedes albopictus in urban Amazonia. PLoS One (2013) 0.87
Developing a vulnerability mapping methodology: applying the water-associated disease index to dengue in Malaysia. PLoS One (2013) 0.87
Dengue seroprevalence and risk factors for past and recent viral transmission in Venezuela: a comprehensive community-based study. Am J Trop Med Hyg (2014) 0.86
Epidemiological Scenario of Dengue in Brazil. Biomed Res Int (2015) 0.86
Complete genome sequencing and phylogenetic analysis of dengue type 1 virus isolated from Jeddah, Saudi Arabia. Virol J (2015) 0.86
Dengue virus infections among Haitian and expatriate non-governmental organization workers--Léogane and Port-au-Prince, Haiti, 2012. PLoS Negl Trop Dis (2014) 0.86
Detection of a new insect flavivirus and isolation of Aedes flavivirus in Northern Italy. Parasit Vectors (2012) 0.85
Accuracy of clinical criteria and an immunochromatographic strip test for dengue diagnosis in a DENV-4 epidemic. BMC Infect Dis (2016) 0.85
Disease severity and mortality caused by dengue in a Dominican pediatric population. Am J Trop Med Hyg (2013) 0.85
Introducing a dengue vaccine to Mexico: development of a system for evidence-based public policy recommendations. PLoS Negl Trop Dis (2014) 0.84
Physician survey to determine how dengue is diagnosed, treated and reported in puerto rico. PLoS Negl Trop Dis (2014) 0.84
Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission. Infect Genet Evol (2011) 0.84
Genome sequence analysis of dengue virus 1 isolated in Key West, Florida. PLoS One (2013) 0.83
Country- and age-specific optimal allocation of dengue vaccines. J Theor Biol (2013) 0.83
Aedes aegypti (Diptera: Culicidae): evaluation of natural long-lasting materials containing pyriproxyfen to improve control strategies. Parasitol Res (2014) 0.83
Epidemiological Trend and Clinical Observations among Children and Adults with Dengue in Barbados. West Indian Med J (2015) 0.82
Projected Impact of Dengue Vaccination in Yucatán, Mexico. PLoS Negl Trop Dis (2016) 0.82
Insecticide-driven patterns of genetic variation in the dengue vector Aedes aegypti in Martinique Island. PLoS One (2013) 0.82
Improved dengue fever prevention through innovative intervention methods in the city of Salto, Uruguay. Trans R Soc Trop Med Hyg (2015) 0.82
Dengue in Latin America: Systematic Review of Molecular Epidemiological Trends. PLoS Negl Trop Dis (2017) 0.82
Understanding Water Storage Practices of Urban Residents of an Endemic Dengue Area in Colombia: Perceptions, Rationale and Socio-Demographic Characteristics. PLoS One (2015) 0.81
Investigating the genetics of Bti resistance using mRNA tag sequencing: application on laboratory strains and natural populations of the dengue vector Aedes aegypti. Evol Appl (2013) 0.81
Quality of life among adults with confirmed dengue in Brazil. Am J Trop Med Hyg (2011) 0.81
Time series analysis of onchocerciasis data from Mexico: a trend towards elimination. PLoS Negl Trop Dis (2013) 0.81
Graph hierarchies for phylogeography. Philos Trans R Soc Lond B Biol Sci (2013) 0.81
Evaluation of dengue fever reports during an epidemic, Colombia. Rev Saude Publica (2014) 0.81
Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database. Eur J Health Econ (2015) 0.81
Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice. J Virol (2015) 0.80
Multiple Introductions of Dengue 2 Virus Strains into Saudi Arabia from 1992 to 2014. Vector Borne Zoonotic Dis (2016) 0.79
Dynamic spatiotemporal trends of imported dengue fever in Australia. Sci Rep (2016) 0.79
Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel. Fam Pract (2014) 0.79
Temporal abundance of Aedes aegypti in Manaus, Brazil, measured by two trap types for adult mosquitoes. Mem Inst Oswaldo Cruz (2014) 0.78
Dengue virus type 3 adaptive changes during epidemics in São Jose de Rio Preto, Brazil, 2006-2007. PLoS One (2013) 0.78
Severe dengue virus infection in pediatric travelers visiting friends and relatives after travel to the Caribbean. Am J Trop Med Hyg (2012) 0.78
Risk factors associated with death in Brazilian children with severe dengue: a case-control study. Clinics (Sao Paulo) (2014) 0.77
The State of the Art of Lethal Oviposition Trap-Based Mass Interventions for Arboviral Control. Insects (2017) 0.77
Evidence of HLA-DQB1 Contribution to Susceptibility of Dengue Serotype 3 in Dengue Patients in Southern Brazil. J Trop Med (2014) 0.77
Diagnostic efficacy of saliva for dengue - a reality in near future? A piloting initiative. J Clin Diagn Res (2014) 0.77
Spatiotemporal dynamics of DENV-2 Asian-American genotype lineages in the Americas. PLoS One (2014) 0.77
Detection of all four dengue serotypes in Aedes aegypti female mosquitoes collected in a rural area in Colombia. Mem Inst Oswaldo Cruz (2016) 0.77
Spatial Distribution of Epidemiological Cases of Dengue Fever in Suriname, 2001-2012. West Indian Med J (2015) 0.77
Association of FcγRIIa Polymorphism with Clinical Outcome of Dengue Infection: First Insight from Pakistan. Am J Trop Med Hyg (2015) 0.76
The Burden of Dengue and the Financial Cost to Colombia, 2010-2012. Am J Trop Med Hyg (2016) 0.76
Carnival or football, is there a real risk for acquiring dengue fever in Brazil during holidays seasons? Sci Rep (2015) 0.76
High prevalence of previous dengue virus infection among first-generation Surinamese immigrants in the Netherlands. BMC Infect Dis (2014) 0.75
Societal impact of dengue outbreaks: Stakeholder perceptions and related implications. A qualitative study in Brazil, 2015. PLoS Negl Trop Dis (2017) 0.75
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
Risk factors in dengue shock syndrome. Am J Trop Med Hyg (1997) 3.83
Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg (2005) 3.12
Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol (2003) 2.90
Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ (1989) 2.90
Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica (2006) 2.84
A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg (1999) 2.78
Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat Q (1997) 2.59
Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica (2009) 2.45
Hemorrhagic dengue in Cuba: history of an epidemic. Bull Pan Am Health Organ (1986) 2.07
Short communication: impact of climate variability on the incidence of dengue in Mexico. Trop Med Int Health (2007) 1.88
Recent shift in age pattern of dengue hemorrhagic fever, Brazil. Emerg Infect Dis (2008) 1.77
Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans R Soc Trop Med Hyg (1987) 1.74
Dengue virus type 3, Brazil, 2002. Emerg Infect Dis (2005) 1.64
[Dengue outbreak in Boa Vista, Roraima. Preliminary report]. Rev Inst Med Trop Sao Paulo (1983) 1.56
An outbreak of dengue virus at Rio de Janeiro--1986. Mem Inst Oswaldo Cruz (1987) 1.46
[Integrated strategy for dengue prevention and control in the Region of the Americas]. Rev Panam Salud Publica (2007) 1.43
Dengue epidemic in the stage of Rio de Janeiro, Brazil, 1990-1: co-circulation of dengue 1 and dengue 2 serotypes. Epidemiol Infect (1993) 1.37
[Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas]. Bol Oficina Sanit Panam (1996) 1.37
Epidemiological and clinical observations on patients with dengue in Puerto Rico: results from the first year of enhanced surveillance--June 2005-May 2006. Am J Trop Med Hyg (2008) 1.27
Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution. Am J Trop Med Hyg (2005) 1.22
Dengue epidemic in Belém, Pará, Brazil, 1996-97. Emerg Infect Dis (2000) 1.19
Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995-2006. Rev Soc Bras Med Trop (2008) 1.17
Is climate change affecting dengue in the Americas? Lancet (2008) 1.17
Molecular epidemiology of dengue virus serotypes 2 and 3 in Paraguay during 2001-2006: the association of viral clade introductions with shifting serotype dominance. Virus Res (2008) 1.11
[Dengue and dengue hemorrhagic fever: research priorities]. Rev Panam Salud Publica (2006) 1.09
Dengue fever in Brazilian adults and children: assessment of clinical findings and their validity for diagnosis. Ann Trop Med Parasitol (2003) 1.07
A large epidemic of dengue fever with dengue hemorrhagic cases in Ceará State, Brazil, 1994. Rev Inst Med Trop Sao Paulo (1996) 1.00
The dynamics of dengue virus serotype 3 introduction and dispersion in the state of Bahia, Brazil. Mem Inst Oswaldo Cruz (2007) 0.96
[Dengue and hemorrhagic dengue in the Americas]. Rev Panam Salud Publica (2007) 0.95
Dengue hemorrhagic fever in Venezuela. Epidemiol Bull (1990) 0.91
Humoral immune response of dengue hemorrhagic fever cases in children from Tegucigalpa, Honduras. Am J Trop Med Hyg (2008) 0.90
Dengue virus (serotype 3) circulation in endemic countries and its reappearance in America. Arch Med Res (2000) 0.88
Dengue in the Americas. An update. Epidemiol Bull (1993) 0.86
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet (2012) 12.41
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med (2014) 6.58
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med (2015) 4.79
Economic impact of dengue illness in the Americas. Am J Trop Med Hyg (2011) 3.52
Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med (2006) 3.33
Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis (2009) 2.26
Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol (2003) 2.22
The history of dengue outbreaks in the Americas. Am J Trop Med Hyg (2012) 1.87
Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis (2007) 1.87
Seroprevalence of antibody to mumps virus in the US population, 1999-2004. J Infect Dis (2010) 1.70
IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol (2004) 1.50
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity. Pediatr Infect Dis J (2011) 1.37
HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol (2007) 1.29
Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis (2008) 1.26
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine (2006) 1.24
Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol (2007) 1.23
Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children. PLoS Negl Trop Dis (2013) 1.18
Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis (2011) 1.17
PCR detection of dengue virus using dried whole blood spotted on filter paper. J Virol Methods (2005) 1.14
Measles outbreak in the Republic of the Marshall Islands, 2003. Int J Epidemiol (2005) 1.14
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis (2012) 1.12
Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis (2008) 1.12
Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis (2004) 1.10
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine (2012) 1.09
Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America. Pediatr Infect Dis J (2013) 1.07
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore. Hum Vaccin Immunother (2012) 1.06
Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg (2010) 1.02
Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol (2008) 1.02
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates. Antiviral Res (2008) 1.00
Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine (2010) 1.00
Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J (2010) 0.99
[Economic impact of dengue 2 epidemic in Santiago de Cuba, 1997]. Rev Cubana Med Trop (2005) 0.98
Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J (2009) 0.98
Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants. Pediatr Infect Dis J (2012) 0.97
Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol (2007) 0.97
Diagnosis of dengue virus infection by the visual and simple AuBioDOT immunoglobulin M capture system. Clin Diagn Lab Immunol (2003) 0.97
Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Hum Vaccin Immunother (2012) 0.96
[Dengue and hemorrhagic dengue in the Americas]. Rev Panam Salud Publica (2007) 0.95
Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol (2006) 0.95
Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice. Virus Res (2006) 0.94
Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic. Int J Infect Dis (2008) 0.93
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice. Virology (2009) 0.93
Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru. Vaccine (2012) 0.93
Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins. Arch Virol (2008) 0.93
[Society, economy, inequities and dengue]. Rev Cubana Med Trop (2013) 0.92
Long-term memory cellular immune response to dengue virus after a natural primary infection. Int J Infect Dis (2002) 0.91
Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study. Vaccine (2013) 0.89
Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years. Vaccine (2010) 0.88
Association of MICA and MICB alleles with symptomatic dengue infection. Hum Immunol (2011) 0.88
Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice. Clin Diagn Lab Immunol (2005) 0.87
A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis (2009) 0.87
Oxidative stress in adult dengue patients. Am J Trop Med Hyg (2004) 0.87
A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice. J Virol Methods (2004) 0.87
A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005. J Clin Virol (2008) 0.86
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico. Hum Vaccin Immunother (2014) 0.86
Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis. Vaccine (2008) 0.85
Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J (2014) 0.84
Efficacy of the human rotavirus vaccine RIX4414 in malnourished children. J Infect Dis (2007) 0.84
A fragment of the envelope protein from dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice. Biotechnol Appl Biochem (2004) 0.83
The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2. Clin Vaccine Immunol (2011) 0.83
Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. Pediatr Infect Dis J (2004) 0.83
Apoptosis, vascular leakage and increased risk of severe dengue in a type 2 diabetes mellitus patient. Diab Vasc Dis Res (2008) 0.83
Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998-2003. J Med Virol (2008) 0.82
Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use. Int J Infect Dis (2009) 0.82
Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore. Hum Vaccin Immunother (2013) 0.82
A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus. Vaccine (2006) 0.81
Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus. Virus Res (2008) 0.81
Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' reply. Lancet (2013) 0.81
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India. BMC Infect Dis (2014) 0.81
Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children. Hum Vaccin Immunother (2013) 0.80
The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice. Vaccine (2011) 0.80
Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice. Int Immunol (2009) 0.80
Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus. Arch Virol (2012) 0.79
Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants. Pediatr Infect Dis J (2011) 0.79
Introduction of human rotavirus vaccine in Latin America. Arch Med Res (2006) 0.78
Prevalence of febrile syndromes in dengue surveillance, havana city, 2007. MEDICC Rev (2011) 0.78
Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus. Am J Trop Med Hyg (2012) 0.78
Guidance for isolation precautions for mumps in the United States: a review of the scientific basis for policy change. Clin Infect Dis (2010) 0.78
The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs. Biochem Biophys Res Commun (2003) 0.78
A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice. Arch Virol (2014) 0.77
Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice. J Gen Virol (2012) 0.77
Expression in Pichia pastoris and immunological evaluation of a truncated Dengue envelope protein. Mol Biotechnol (2007) 0.77
Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies. Vaccine (2003) 0.77
Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design. Virus Genes (2014) 0.77
Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice. Biotechnol Appl Biochem (2009) 0.77
Mumps surveillance and prevention: putting mumps back on our radar screen. Cleve Clin J Med (2007) 0.77
Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial. Pediatr Infect Dis J (2016) 0.76
Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus. Arch Virol (2014) 0.76
Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea. Pediatr Infect Dis J (2016) 0.75
Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination with Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children. Pediatr Infect Dis J (2016) 0.75
Risk factors for mumps at a university with a large mumps outbreak. Public Health Rep (2009) 0.75
Biological and Molecular Properties of Dengue 2 Strains Isolated during the DHF/DSS Cuban Epidemic, 1981. Int J Biomed Sci (2007) 0.75
A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea. Hum Vaccin Immunother (2014) 0.75